A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/454 (2006.01) A61K 9/48 (2006.01) A61K 47/12 (2006.01) A61K 47/36 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2505964
Pharmaceutical compositions and single unit dosage forms of thalidomide and pharmaceutically acceptable prodrugs, salts, solvates, hydrates, or clathrates are disclosed. Also disclosed are methods of treating and preventing diseases and conditions such as, but not limited to, leprosy, chronic graft-vs-host disease, rheumatoid arthritis, sarcoidosis, an inflammatory condition, inflammatory bowel disease, and cancer using the novel dosage forms disclosed herein.
L'invention concerne des compositions pharmaceutiques et des formes de dosage unitaires de la thalidomide et de pro-médicaments, sels, solvates, hydrates ou clathrates pharmaceutiquement acceptables. L'invention concerne en outre des procédés de traitement et de prévention de maladies et d'états tels que mentionnés ci-après, sans caractère limitatif : lèpre, rejet de greffe chronique, arthrite rhumatoïde, sarcoïdose, état inflammatoire, maladie intestinale inflammatoire, et cancer, au moyen de ces nouvelles formes de dosage.
Celgene Corporation
Smart & Biggar
LandOfFree
Pharmaceutical compositions and dosage forms of thalidomide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions and dosage forms of thalidomide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions and dosage forms of thalidomide will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1614587